{"id":"https://openalex.org/W2252815230","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.2524","title":"Population pharmacokinetics of CP-751,871, a monoclonal antibody against IGF-I receptor, in patients with multiple myeloma or solid tumors","display_name":"Population pharmacokinetics of CP-751,871, a monoclonal antibody against IGF-I receptor, in patients with multiple myeloma or solid tumors","publication_year":2008,"publication_date":"2008-05-20","ids":{"openalex":"https://openalex.org/W2252815230","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.2524","mag":"2252815230"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2008.26.15_suppl.2524","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.2524","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.2524","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"D. Yin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Yin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010946186","display_name":"Maria Luisa Paccagnella","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. L. Paccagnella","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110162073","display_name":"M. Q. Lacy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Q. Lacy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. S. De Bono","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018097320","display_name":"P. Haluska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Haluska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021891844","display_name":"Antonio Gualberto","orcid":"https://orcid.org/0000-0002-6590-839X","observed_orcids":["https://orcid.org/0000-0002-6590-839X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Gualberto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112070835","display_name":"Alexis Behne Sharma","orcid":"https://orcid.org/0009-0004-1849-1108","observed_orcids":["https://orcid.org/0009-0004-1849-1108","https://orcid.org/0009-0003-7523-6886"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Sharma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"15_suppl","first_page":"2524","last_page":"2524"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8496000170707703,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8496000170707703,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.04039999842643738,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.032099999487400055,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.6380000114440918},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9319999814033508},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.9120000004768372},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":1.0},{"id":"https://openalex.org/keywords/body-weight-covariate","display_name":"body weight covariate","score":0.8500000238418579},{"id":"https://openalex.org/keywords/plasma-clearance","display_name":"plasma clearance","score":0.7099999785423279},{"id":"https://openalex.org/keywords/saturable-elimination","display_name":"saturable elimination","score":0.777999997138977},{"id":"https://openalex.org/keywords/nonlinear-mixed-effects-models","display_name":"nonlinear mixed-effects models","score":0.6399999856948853},{"id":"https://openalex.org/keywords/dosage","display_name":"dosage","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7647114992141724},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7114853262901306},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6615747213363647},{"id":"https://openalex.org/C2776239304","wikidata":"https://www.wikidata.org/wiki/Q6954915","display_name":"NONMEM","level":3,"score":0.6586673259735107},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5818920731544495},{"id":"https://openalex.org/C119043178","wikidata":"https://www.wikidata.org/wiki/Q320723","display_name":"Covariate","level":2,"score":0.5088891983032227},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.4989645481109619},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49212783575057983},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4341670274734497},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40073928236961365},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39023393392562866},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3337338864803314},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.07447579503059387},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2008.26.15_suppl.2524","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.2524","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.2524","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1979111072","https://openalex.org/W4322616597","https://openalex.org/W3083499477","https://openalex.org/W2112474467","https://openalex.org/W2269588062","https://openalex.org/W2246798259","https://openalex.org/W4292682020","https://openalex.org/W1979794702","https://openalex.org/W3204946844","https://openalex.org/W7131248328"],"abstract_inverted_index":{"2524":[0],"Background:":[1],"CP-751,871,":[2],"a":[3,35,126,163,174,239],"fully":[4],"human":[5],"IgG2":[6],"monoclonal":[7],"antibody":[8],"against":[9],"the":[10,29,40,76,94,101,132,156,177,182,225,246],"insulin-like":[11],"growth":[12],"factor":[13],"type":[14],"I":[15],"receptor":[16],"(IGF-IR),":[17],"is":[18],"currently":[19],"under":[20],"clinical":[21],"development":[22],"for":[23,38,176,242,252],"cancer":[24,46,137,231,270],"treatment.":[25],"The":[26,233,254],"aim":[27],"of":[28,43,70,79,134,228,235,248,267],"present":[30],"work":[31],"was":[32,88,148,159,171,203,221],"to":[33,81,92,112,223,261],"develop":[34],"population":[36,218,255],"model":[37,96,124,220,257],"characterizing":[39],"pharmacokinetics":[41],"(PK)":[42],"CP-751,871":[44,49,71,98,135,198,229,268],"in":[45,75,136,144,207,230,269],"patients.":[47,138,215,232,271],"Methods:":[48],"concentration-time":[50,226],"data":[51],"were":[52,116],"obtained":[53],"from":[54],"34":[55],"patients":[56,62],"with":[57,63,125],"multiple":[58,210],"myeloma":[59,211],"and":[60,100,106,155,181,188,212],"46":[61],"solid":[64,213],"tumors,":[65],"who":[66],"received":[67],"escalating":[68],"doses":[69],"via":[72],"intravenous":[73],"infusions":[74],"dose":[77],"range":[78],"0.1":[80],"20":[82],"mg/kg.":[83],"Nonlinear":[84],"mixed":[85],"effects":[86,196],"modeling":[87],"conducted":[89],"using":[90],"NONMEM":[91],"obtain":[93],"structural":[95,122],"describing":[97,104],"disposition":[99,133,146],"statistic":[102],"models":[103],"intra-":[105],"inter-patient":[107,113,142],"variabilities.":[108],"Possible":[109],"covariates":[110],"contributing":[111],"PK":[114,123,145,208,219,256],"variability":[115,143,158],"also":[117],"explored.":[118],"Results:":[119],"A":[120,217],"mechanism-based":[121],"saturable":[127],"elimination":[128],"process":[129],"best":[130,160],"described":[131,149,161],"For":[139],"variance":[140],"models,":[141],"parameters":[147],"by":[150,162],"an":[151],"exponential":[152],"error":[153,167],"model,":[154],"residual":[157,166],"log-normal":[164],"additive":[165],"model.":[168],"Body":[169],"weight":[170,237],"identified":[172],"as":[173,238],"covariate":[175,241],"initial":[178],"distribution":[179],"volume":[180],"plasma":[183,243],"clearance":[184,244],"parameters.":[185],"Age,":[186],"sex,":[187],"albumin":[189],"or":[190,275,278],"bilirubin":[191],"concentrations":[192],"showed":[193],"no":[194,204],"apparent":[195,205],"on":[197],"PK.":[199],"In":[200],"addition,":[201],"there":[202],"difference":[206],"between":[209],"tumor":[214],"Conclusions:":[216],"developed":[222],"describe":[224],"profiles":[227],"identification":[234],"body":[236,249],"significant":[240],"validates":[245],"appropriateness":[247],"weight-based":[250],"dosing":[251],"CP-751,871.":[253],"can":[258],"be":[259],"applied":[260],"further":[262],"explore":[263],"pharmacokinetic/pharmacodynamic":[264],"(PK/PD)":[265],"relationships":[266],"Author":[272],"Disclosure":[273],"Employment":[274],"Leadership":[276],"Consultant":[277],"Advisory":[279],"Role":[280],"Stock":[281],"Ownership":[282],"Honoraria":[283],"Research":[284],"Expert":[285],"Testimony":[286],"Other":[287],"Remuneration":[288],"Pfizer":[289,291,293,295],"Oncology":[290,292,294,296]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}